Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
valaciclovir (Valtrex) (1 trial)
valomaciclovir stearate (2 trials)
Communicable Diseases (Phase 2)
Epstein-Barr Virus Infections (Phase 2)
Herpes Zoster (Phase 2)
Infections (Phase 2)
Infectious Mononucleosis (Phase 2)
Virus Diseases (Phase 2)
Trials (2 total)
Trial APIs (2 total)